Search research articles
Contact Us
Filters
Showing results (251-260 of 334) with videos related to
Page
of 34
Sort By:
The Gerontologist
|
September 25, 1999
Home-based multidisciplinary diagnosis and treatment of inner-city elders with dementia
D F Edwards, C M Baum, M Meisel, et al.
Neuroimage
|
April 6, 2005
Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly
J G Csernansky, L Wang, J Swank, et al.
The Journal of Cell Biology
|
March 1, 1994
A glycosylphosphatidylinositol (GPI)-negative phenotype produced in Leishmania major by GPI phospholipase C from Trypanosoma brucei: topography of two GPI pathways
K Mensa-Wilmot, J H LeBowitz, K P Chang, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
February 1, 1994
GPI phospholipase C from Trypanosoma brucei causes a GPI-negative phenotype in Leishmania major: I. Implications for GPI-negative mammalian cells; II. Compartmentalization of two GPI biosynthetic pathways
K Mensa-Wilmot, J H LeBowitz, K P Chang, et al.
Neurology
|
September 26, 2002
The clock drawing test is a poor screen for very mild dementia
K K Powlishta, D D Von Dras, A Stanford, et al.
Kidney International
|
March 7, 2001
Expression of the sodium iodide symporter in human kidney
C Spitzweg, C M Dutton, M R Castro, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1993
Interlaboratory histopathologic assessment of Alzheimer neuropathology: different methodologies yield comparable diagnostic results
D W McKeel, M J Ball, J L Price, et al.
Neurology
|
July 7, 2010
Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept
C M Roe, M A Mintun, N Ghoshal, et al.
Nuklearmedizin. Nuclear Medicine
|
May 7, 2004
Pancreatic carcinoma with positive iodine uptake lacking NIS-protein-expression
N Döbert, N Hamscho, E R Bergert, et al.
Clinical Therapeutics
|
June 9, 2001
Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Panel discussion: recommendations for prescribers
J C Morris, M R Farlow, S H Ferris, et al.
Page
of 34
Search research articles
Search
Showing results (251-260 of 334) with videos related to
Sort By:
Page
of 34
The Gerontologist
|
September 25, 1999
Home-based multidisciplinary diagnosis and treatment of inner-city elders with dementia
D F Edwards, C M Baum, M Meisel, et al.
Neuroimage
|
April 6, 2005
Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly
J G Csernansky, L Wang, J Swank, et al.
The Journal of Cell Biology
|
March 1, 1994
A glycosylphosphatidylinositol (GPI)-negative phenotype produced in Leishmania major by GPI phospholipase C from Trypanosoma brucei: topography of two GPI pathways
K Mensa-Wilmot, J H LeBowitz, K P Chang, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
February 1, 1994
GPI phospholipase C from Trypanosoma brucei causes a GPI-negative phenotype in Leishmania major: I. Implications for GPI-negative mammalian cells; II. Compartmentalization of two GPI biosynthetic pathways
K Mensa-Wilmot, J H LeBowitz, K P Chang, et al.
Neurology
|
September 26, 2002
The clock drawing test is a poor screen for very mild dementia
K K Powlishta, D D Von Dras, A Stanford, et al.
Kidney International
|
March 7, 2001
Expression of the sodium iodide symporter in human kidney
C Spitzweg, C M Dutton, M R Castro, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1993
Interlaboratory histopathologic assessment of Alzheimer neuropathology: different methodologies yield comparable diagnostic results
D W McKeel, M J Ball, J L Price, et al.
Neurology
|
July 7, 2010
Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept
C M Roe, M A Mintun, N Ghoshal, et al.
Nuklearmedizin. Nuclear Medicine
|
May 7, 2004
Pancreatic carcinoma with positive iodine uptake lacking NIS-protein-expression
N Döbert, N Hamscho, E R Bergert, et al.
Clinical Therapeutics
|
June 9, 2001
Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Panel discussion: recommendations for prescribers
J C Morris, M R Farlow, S H Ferris, et al.
Page
of 34